Sartocube® Self-Contained Unit | Hydrosart® | 30 kDa mAb | 12.36 m²

Sartocon® Q and Sartocube® Q self-contained units are ready-to-use devices for sterile and aseptic processing. Combined with Hydrosart® 30kDa mAb membrane, they enable fast and efficient mAb concentration, coming pre-flushed and sterile, eliminating pre-use preparation.

Filtration Area
Item No.: 
SFM-AQ-14460A2
*Custom/bulk order quotes are provided within 72 hours of request.
Sartocube® Self-Contained Unit | Hydrosart® | 30 kDa mAb | 12.36 m²
Sartocube® Self-Contained Unit | Hydrosart® | 30 kDa mAb | 12.36 m²

Sartocon® Q and Sartocube® Q self-contained units are ready-to-use devices for sterile and aseptic processing. Combined with Hydrosart® 30kDa mAb membrane, they enable fast and efficient mAb concentration, coming pre-flushed and sterile, eliminating pre-use preparation.

Item No.:
SFM-AQ-14460A2

Overview

Specifications

Sartocon® Q and Sartocube® Q self-contained units are ready-to-use devices for sterile and aseptic processing. Combined with Hydrosart® 30kDa mAb membrane, they enable fast and efficient mAb concentration.

Advantages

· Delivered pre-flushed, sterile & ready to use

· No CIP and cleaning validation necessary

· Increased flexibility combined with time savings

The new Sartocon® Q Hydrosart® 30 kDa mAb SCU features the new Q screen design for final viscosities between 3-30cP, combined with an mAb optimized 30kDa cut off.

Our Hydrosart® 30kDa membrane is a high-performance, stabilized cellulose-based membrane optimized for monoclonal antibody processing.

· Extremely hydrophilic, ensuring non-protein binding and virtually non-fouling properties.

· Exceptionally cleanable, with high caustic stability, providing a long-life cycle with stable performance in flux and retention.

Typical applications within aseptic processing:

· Concentration of monoclonal antibodies (mAbs)

· Volume reduction of buffer exchange

This new cassette type was specifically optimized for monoclonal antibody applications but is also suitable for molecules of similar size, as well as e.g. bispecific antibodies.

Compliance and quality

Sartorius TFF products comply with global regulatory and quality standards (see specification area) and are tested for integrity during final release.

Sartocon® Q & Sartocube® Q SCU are ideally combined with Sartorius Sartocon® holders and Sartoflow® systems.

Applications

  • Industry
    Pharma / Biotech

Compliance Information

  • Bacterial Endotoxins
    < 0.18 EU/mL as determined by the LAL test
  • Biological Reactivity
    All materials of this filter element meet the requirements of the current USP Biological Reactivity tests <88> for plastics Class VI (Systemic Injection, Intracutaneous and Implantation tests).
  • Extractables
    The total amount of extractables is well below the limits established by the current USP unter "Sterile Water for Injection".

Dimensions

  • Channel Height
    Q-Screen (Medium viscosity)
  • Filtration Area
    12.36 m²
  • Flow Channel Geometry
    Viscosity 3–30 cp

General Specifications

  • Cassette Format
    Sartocube® SCU
  • Filter Class
    Ultrafilter

Materials of Construction

  • Membrane Material
    Hydrosart®
  • Sealing Compound
    Silicone Grey
  • Spacer
    Polysulfone

Operating Conditions

  • Maximum Inlet Pressure
    4 bar
  • pH Stability
    pH 2 - 14

Physicochemical Information

  • MWCO
    30 kDa mAb
  • Non-Fiber Releasing
    This filter product complies with the title 21 of the Code of Federal Regulations (CFR), section 210.3(b)(6) and 211.72.

Product Information

  • Brand
    Sartocube®
  • Pack Size
    1